100 related articles for article (PubMed ID: 21327679)
1. The contribution of SK3 polymorphisms to acute oxaliplatin-induced neurotoxicity: direct or indirect effects?
Park SB; Lin CS; Krishnan AV; Kiernan MC
Cancer Chemother Pharmacol; 2011 May; 67(5):1189-90; author reply 1191-2. PubMed ID: 21327679
[No Abstract] [Full Text] [Related]
2. Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity.
Basso M; Modoni A; Spada D; Cassano A; Schinzari G; Lo Monaco M; Quaranta D; Tonali PA; Barone C
Cancer Chemother Pharmacol; 2011 May; 67(5):1179-87. PubMed ID: 20872144
[TBL] [Abstract][Full Text] [Related]
3. Possible association of CAG repeat polymorphism in KCNN3 encoding the potassium channel SK3 with oxaliplatin-induced neurotoxicity.
Anon B; Largeau B; Girault A; Chantome A; Caulet M; Perray C; Moussata D; Vandier C; Barin-Le Guellec C; Lecomte T
Cancer Chemother Pharmacol; 2018 Jul; 82(1):149-157. PubMed ID: 29774408
[TBL] [Abstract][Full Text] [Related]
4. Peripheral neuropathy induced by oxaliplatin-based chemotherapy.
J Support Oncol; 2006 Feb; 4(2):82-3. PubMed ID: 16499128
[No Abstract] [Full Text] [Related]
5. [Genetic backgrounds of peripheral neuropathy induced by oxaliplatin].
Mitsuma A; Ando Y
Nihon Yakurigaku Zasshi; 2013 Feb; 141(2):62-5. PubMed ID: 23391543
[No Abstract] [Full Text] [Related]
6. Oxaliplatin-induced neuropathy: a tale of two electrolytes.
Babiker HM; Green MR; Nelson MA; Elquza E
Support Care Cancer; 2015 Jun; 23(6):1483-5. PubMed ID: 25801447
[No Abstract] [Full Text] [Related]
7. Liability of the voltage-gated sodium channel gene SCN2A R19K polymorphism to oxaliplatin-induced peripheral neuropathy.
Argyriou AA; Antonacopoulou AG; Scopa CD; Kottorou A; Kominea A; Peroukides S; Kalofonos HP
Oncology; 2009; 77(3-4):254-6. PubMed ID: 19738391
[TBL] [Abstract][Full Text] [Related]
8. [Roles of TRPA1 in acute peripheral neuropathy characteristically induced by oxaliplatin].
Nakagawa T; Zhao M; Shirakawa H; Kaneko S
Nihon Yakurigaku Zasshi; 2013 Feb; 141(2):76-80. PubMed ID: 23391546
[No Abstract] [Full Text] [Related]
9. New data question treatment for oxaliplatin neurotoxicity.
Wolf SL
Clin J Oncol Nurs; 2008 Feb; 12(1):14; author reply 14. PubMed ID: 18323035
[No Abstract] [Full Text] [Related]
10. [Evidence from basic studies on mechanisms and treatment drugs for oxaliplatin-induced peripheral neuropathy].
Egashira N; Kawashiri T; Oishi R
Nihon Yakurigaku Zasshi; 2013 Feb; 141(2):66-70. PubMed ID: 23391544
[No Abstract] [Full Text] [Related]
11. SK3 Gene Polymorphism Is Associated with Taxane Neurotoxicity and Cell Calcium Homeostasis.
Rua C; Guéguinou M; Soubai I; Viel E; Potier-Cartereau M; Chantome A; Barbe C; Bougnoux P; Barin-Le Guellec C; Vandier C
Clin Cancer Res; 2018 Nov; 24(21):5313-5320. PubMed ID: 30037821
[No Abstract] [Full Text] [Related]
12. Calcium and magnesium for oxaliplatin-induced neuropathy.
Stansfield L
Am J Health Syst Pharm; 2014 Jun; 71(12):987-8. PubMed ID: 24865753
[No Abstract] [Full Text] [Related]
13. Xaliproden lessens oxaliplatin-mediated neuropathy.
Susman E
Lancet Oncol; 2006 Apr; 7(4):288. PubMed ID: 16598880
[No Abstract] [Full Text] [Related]
14. The pain with platinum: oxaliplatin and neuropathy.
Kiernan MC
Eur J Cancer; 2007 Dec; 43(18):2631-3. PubMed ID: 17977714
[No Abstract] [Full Text] [Related]
15. Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: a genome-wide study replication and meta-analysis.
Terrazzino S; Argyriou AA; Cargnin S; Antonacopoulou AG; Briani C; Bruna J; Velasco R; Alberti P; Campagnolo M; Lonardi S; Cortinovis D; Cazzaniga M; Santos C; Kalofonos HP; Canonico PL; Genazzani AA; Cavaletti G
J Peripher Nerv Syst; 2015 Mar; 20(1):15-23. PubMed ID: 25858589
[TBL] [Abstract][Full Text] [Related]
16. [Peripheral Nerve Toxicity Caused by Oxaliplatin: Research Progress of Integrative Medicine].
Zhang D; Yang YF
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Aug; 35(8):1022-4. PubMed ID: 26485922
[No Abstract] [Full Text] [Related]
17. [Basic evidence for efficacy of Goshajinkigan on oxaliplatin-induced neuropathy].
Ushio S; Kawashiri T; Egashira N
Nihon Yakurigaku Zasshi; 2014 Mar; 143(3):126-30. PubMed ID: 24614635
[No Abstract] [Full Text] [Related]
18. [Role of Transient Receptor Potential Channels in Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy].
Taguchi K
Yakugaku Zasshi; 2016; 136(2):287-96. PubMed ID: 26831807
[TBL] [Abstract][Full Text] [Related]
19. The case of the tingling toes.
Eisenberg S
ONS Connect; 2011 Sep; 26(9):17. PubMed ID: 21954796
[No Abstract] [Full Text] [Related]
20. Oxaliplatin-associated neuropathy: a review.
Cersosimo RJ
Ann Pharmacother; 2005 Jan; 39(1):128-35. PubMed ID: 15590869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
